Arriving in the landscape of weight management treatment, retatrutide represents a distinct method. Beyond many available medications, retatrutide functions as a dual agonist, simultaneously engaging both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) binding sites. This dual stimulation encourages multiple adv